País: Irlanda
Idioma: inglés
Fuente: HPRA (Health Products Regulatory Authority)
Melatonin
Pharma Nord ApS
N05CH01
Melatonin
3 milligram(s)
Film-coated tablet
melatonin
2019-11-15
1 PACKAGE LEAFLET: INFORMATION FOR THE USER MELATONIN PHARMA NORD 3 MG, FILM-COATED TABLETS melatonin READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. - You must talk to a doctor if you do not feel better or if you feel worse after 5 days. WHAT IS IN THIS LEAFLET 1. What Melatonin Pharma Nord is and what it is used for 2. What you need to know before you take Melatonin Pharma Nord 3. How to take Melatonin Pharma Nord 4. Possible side effects 5. How to store Melatonin Pharma Nord 6. Contents of the pack and other information 1. WHAT MELATONIN PHARMA NORD IS AND WHAT IT IS USED FOR Melatonin Pharma Nord contains the active substance melatonin. Melatonin Pharma Nord can be used for treatment of short-term jet-lag in adults. Jet-lag can be recognized by sleep disturbances, daytime tiredness, fatigue, mild mental impairment, irritability and digestive system disturbances experienced after flying. _How Melatonin Pharma Nord works_ Melatonin is a hormone produced by the body that synchronizes the body’s biological day-and-night rhythm. The biological rhythm can be disturbed by travelling across time zones. This is known as a jet-lag. The symptoms and their severity vary between individuals, but are generally worse and last longer the more time zones are crossed. Melatonin Pharma Nord can help restore the normal day-and-night rhythm and reduce the symptoms. You must talk to a doctor if you do not feel better or if you feel worse after 5 days. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE MELATONIN PHARMA NORD DO NOT TAKE MELATONIN PHARMA NORD • if you are allergic to melatonin or an Leer el documento completo
Health Products Regulatory Authority 22 May 2023 CRN00D7T0 Page 1 of 8 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Melatonin Pharma Nord 3 mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 3 mg melatonin. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film‑coated tablet (tablet). Round, biconvex, clear-coated, white to off-white tablet of 7.5 mm. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Short-term treatment of jet-lag in adults. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The standard dose is 3 mg (1 tablet) daily for a maximum of 5 days. The dose may be increased to 6 mg (2 tablets taken together) if the standard dose does not adequately alleviate symptoms. The dose that adequately alleviates symptoms should be taken for the shortest period. The first dose should be taken on arrival at destination at the habitual bed-time. Due to the potential for incorrectly timed intake of melatonin to have no effect, or to cause an adverse reaction, on re-synchronisation following jet-lag, Melatonin Pharma Nord should not be taken before 20:00 hr or after 04:00 hr at destination. Food can enhance the increase in plasma melatonin concentration (see section 5.2). Intake of melatonin with carbohydrate-rich meals may impair blood glucose control for several hours (see section 4.4). It is recommended that food is not consumed 2 h before and 2 h after intake of Melatonin Pharma Nord. As alcohol can impair sleep and potentially worsen certain symptoms of jet-lag (e.g. headache, morning fatigue, concentration) it is recommended that alcohol is not consumed when taking Melatonin Pharma Nord. Melatonin Pharma Nord may be taken for a maximum of 16 treatment periods per year. Elderly As the pharmacokinetics of melatonin (immediate release) is comparable in young adults and elderly persons in general, no specific dose recommendations for elderly persons are provided (see section 5.2). Renal impairment There is only limited e Leer el documento completo